Clinical Trials Directory

Trials / Unknown

UnknownNCT02148900

Development of a Blood Test for Marfan Syndrome

Status
Unknown
Phase
Study type
Observational
Enrollment
336 (estimated)
Sponsor
Shriners Hospitals for Children · Academic / Other
Sex
All
Age
4 Years – 26 Years
Healthy volunteers
Accepted

Summary

The objective of this study is to determine whether a simple blood test can be a useful clinical tool for monitoring aortic disease in Marfan syndrome and Marfan-related disorders.

Detailed description

The primary objective of this study is to determine whether increased quantitites of circulating microfibril fragments, measured with a simple blood test, are associated with aortic root size and increased growth of the aortic root in Marfan syndrome and related disorders. The secondary objectives of this study are to: (1) Determine a Marfan "signature" profile of circulating microfibril fragments. (2) Determine if high concentrations of fibrillin-1 fragments are associated with large aortic root diameters. (3) Determine which fibrillin-1 fragments are good biomarkers for aortic root growth and size in Marfan syndrome. (4) Determine the relation between fibrillin-1, aortic root diameter, and medical and lifestyle factors reported on questionnaires.

Conditions

Timeline

Start date
2013-05-01
Primary completion
2017-12-01
Completion
2017-12-01
First posted
2014-05-28
Last updated
2017-01-05

Locations

5 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02148900. Inclusion in this directory is not an endorsement.